Along similar lines, reduced BACE1 in CSF was observed in individuals having mild cognitive impairment (MCI) without AD pathophysiology (16.10 pM) than in individuals having MCI with AD pathology (19.28 pM) (Alexopoulos et al., 2018). Here, BACE1 is linked to Alzheimer disease.